I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Cyclohexanemethylamine was used in the synthesis of Schiff?s base ligand, 4-methyl-2,6-bis(cyclohexylmethyliminomethyl)-phenol, which forms hexanuclear zinc(II) complexes. It was used during the synthesis of 1-acyl-4 cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxyl carbamoylcarbazides from the nonsteroidal anti-inflammatory drugs.
Partha Roy; Mario Manassero; Koushik Dhara; Pradyot Banerjee. Synthesis, characterization and fluorescence properties of hexanuclear zinc(II) complexes. Polyhedron. 2009, 28,(6), 1133-1137.
I.Perkovic; I.Butula; M.Kralj; I.Martin-Kleiner; J.Balzarini; D.Hadjipavlou-Litina; A.M.Katsori; B.Zorc. Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants. European Journal of Medicinal Chemistry. 2012, 51,227-238.
Hazard Statements: H226-H314-H318
Flammable liquid and vapour. Causes severe skin burns and eye damage. Causes serious eye damage.
Precautionary Statements: P260u-P201-P280a-P304+P340-P405-P501a
Obtain special instructions before use. Wear protective gloves and eye/face protection. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.